Log inSign up
Matthew Budoff MD
482 posts
user avatar
Matthew Budoff MD
@BudoffMd
Dr Budoff is a preventive cardiologist and Professor of Medicine at the David Geffen School of Medicine (UCLA) and principal investigator at Lundquist Institute
Torrance CA
calciumscan.com
Joined June 2020
44
Following
6,870
Followers
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Jun 18, 2023
    Sad to report that a very physically active 66 year old patient with negative nuclear 2 years ago, taken off statin with 'clean bill of health', just passed away of SCD/MI with severe 3 VD. Wife had to do CPR. Wrong test, wrong answer. Need more CAC testing in asymptomatic pts
    100K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Dec 11, 2023
    This trial doesn't invalidate the lipid hypothesis, is not the final answer (Progression of soft plaque at 1 year is the final study) and is exactly as originally designed - see classic.clinicaltrials.gov/ct2/show/recor… i have no skin in the game. i am just presenting our findings
    70K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Apr 12, 2025
    Dr Alo, as you have published ZERO papers in your lifetime, and have no credibility in the field, calling my work dishonest is not acceptable. The change in NCPV was less than the change in PAV%, as shown in figure 1 in the paper, so if anything we put our worst foot forward.
    user avatar
    Mind Muscle Project
    @mindmusclepro
    Apr 11, 2025
    There are lots of Problems with the latest Keto- CTA study. But the reason many of us are calling it out is because of the huge promotion campaign going behind what can be best described as dishonest work. & The message that's going out to the laymen is "LDL doesn't matter on
    61K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Apr 12, 2025
    These lean, metabolically healthy individuals on a #ketodiet exhibited less coronary plaque and lower rates of plaque progression than I would have expected, with the majority exhibiting minimal progression and several exhibiting regression. This is interesting.
    65K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Nov 11, 2023
    So Honored to have been awarded the physician if the year award by the California chapter of the ACC. So many great clinicians and researchers. Truly humbled. @ACCinTouch
    19K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Apr 18, 2021
    Evaporate Trial presented at #escprev2021 as late breaker, showing Icosapent Ethyl can reduce Lipid Rich Necrotic Core and intraplaque hemorrhage, while increasing fibrous cap thickness on CT angiography. Understanding the mechanism is so important. @DLBHATTMD @SuvasiniL
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    May 24, 2023
    My most important CAC paper to date just hit: healio.com/news/cardiolog… CAC is SECONDARY RISK EQUIVALENT AT score >300 (same cohort, not comparing clinical trial patients to observational studies) @khurramn1 @RonBlankstein @ErinMichos @rblument1
    Image
    Adults with high CAC score at similar risk for CV events as those with established ASCVD
    From healio.com
    40K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Mar 25, 2023
    Nothing lowers risk more than a CAC of zero. see data from MESA. #Powerofzero I trust it in all asymptomatic except the young (< 40 years of age) to derisk my patients, including DM and FH @khurramn1 @rblument1 @RonBlankstein
    Image
    51K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Dec 11, 2023
    If anyone would like to see the presentation (won an award at WCIR), here it is: youtube.com/watch?v=ny2JqA…
    57K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Nov 26, 2023
    Very nice summary of some landmark articles in the world of coronary artery calcium in jacc.org/doi/10.1016/j.… @rblument1
    Image
    21K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Feb 28, 2024
    I still don't understand why colchicine continues to be disrespected - three positive outcome studies and CCTA plaque studies showing benefit, all for a 2a recommendation? sciencedirect.com/science/articl…
    23K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Mar 27, 2024
    Add another 54% of 11,805 patients from Denmark with LDL > 193 mg/dl also with normal CAC. NOT Everyone needs a statin, i hold therapy for CAC Zero unless DM, known ASCVD in this population with no CAC.
    Image
    Image
    user avatar
    Khurram Nasir
    @khurramn1
    Mar 26, 2024
    61% Clinical FH patients with CAC Zero! Mean age 56 Loved the discussion #PowerOfZero getting more acceptance. #FactsAreFacts
    102K
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Oct 28, 2021
    Finally, CT angiography is the preferred test in US for a majority of patients with chest pain, following the UK (NICE) and ESC 2019 Guidelines. Great editorial by @RonBlankstein @DrMarthaGulati @lesleejshaw puts this in clinical perspective
    user avatar
    Ron Blankstein
    @RonBlankstein
    Oct 28, 2021
    Now out: The 2021 Multi Society Chest Pain Guideline A special thanks to the entire writing group led by @DrMarthaGulati and to the countless others who have worked on this over the past several years 👏 @ACCinTouch @AHAScience & all partner societies 👉bit.ly/3bi6nKc
    Image
  • user avatar
    Matthew Budoff MD
    @BudoffMd
    Apr 22, 2025
    Image
    142K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement